Filana Therapeutics (FLNA) Tax Rate (2022 - 2025)
Filana Therapeutics (FLNA) posted Tax Rate of 150.31% for Q4 2025, up 141.79% on a QoQ basis from 359.71% in Q4 2023.
Analysis
Filana Therapeutics (FLNA) Tax Rate (2022 - 2025) Analysis & Trends
Filana Therapeutics has reported Tax Rate for 3 years, with the latest figure at 150.31% in Q4 2025.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 150.31% in Q4 2025; TTM through Jun 2026 was 44.4%, a N/A change from a year earlier, with the FY2025 full-year figure at 122.89%, down 5088.0% from the prior year.
- Tax Rate was 150.31% for Q4 2025 at Filana Therapeutics, up from 359.71% in the prior quarter.
- The five-year high for Tax Rate was 150.31% in Q4 2025, with the low at 359.71% in Q4 2023.
- Average Tax Rate over 3 years is 160.65%, with a median of 272.56% recorded in 2022.
- The largest YoY upside for Tax Rate was 8715 bps in 2023 against a maximum downside of 8715 bps in 2023.
- Over 3 years, Tax Rate stood at 272.56% in 2022, then plunged by 32 bps to 359.71% in 2023, then surged by 142 bps to 150.31% in 2025.
- The last three Tax Rate figures came in at 150.31% (Q4 2025), 359.71% (Q4 2023), and 272.56% (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 150.31% |
| Dec 31, 2023 | -359.71% |
| Dec 31, 2022 | -272.56% |